AIA Hosts Healthcare Financing Summit To Foster Cross-Sector Collaborative Solutions for Hong Kong's Healthcare Sustainable Future
Caption: Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government (centre); Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority (right); and Mr Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau (left), officiating the opening at the Healthcare Financing Summit
The event featured distinguished speakers, including Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government, and Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority, who shared their insights on the future of Hong Kong's healthcare. Discussions focused on the growing challenges of rising healthcare costs, an ageing population, the critical needs to foster price transparency and budgeting for patients, clinical governance in private medical services, and how stakeholders can work together to ensure the long-term sustainability of Hong Kong's healthcare.
Caption: Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, delivers the opening address, highlighting the importance of collaboration across sectors to build a more inclusive and sustainable healthcare system for the community and future generations.
Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, said: 'It is important for society to continue investing in better healthcare. It represents a growing share of our economy - and an even greater share of our hope for a sustainable and resilient future for all generations.
While Hong Kong's healthcare system is widely recognised for its professionalism, trust, and exceptional outcomes, it is facing increasing pressure from demographic shifts, medical inflation, and rising demand across both the public and private sectors.
As an insurer deeply rooted in Hong Kong, AIA is committed to supporting our society in overcoming these pressing challenges. We believe that meaningful change begins with collective action, guided by a shared sense of conscience and responsibility. Thanks to the valuable contributions of all participants, this Summit has brought together an alliance in action—marking the beginning of a shared journey towards building a more inclusive and sustainable healthcare system for our community and future generations.
Yet this is only the beginning. The future depends on the continued, purposeful actions of all stakeholders. Together, we can play a pivotal role in shaping a healthcare system that empowers people to live Healthier, Longer, Better Lives.'
Caption: Alice Liang, Chief Proposition and Healthcare Officer of AIA Hong Kong & Macau, presents her topical address, 'Healthcare - Insurance Industry Experience', sharing data-driven observations and insights on the evolving role of insurers in shaping sustainable healthcare financing models.
Caption: Distinguished speakers, panelists and guests at the Healthcare Financing Summit hosted by AIA Hong Kong & Macau
Caption: The Healthcare Financing Summit bringing together government officials, legislators, regulators, and leaders from the healthcare and insurance industries to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong Kong.
Hashtag: #AIA #友邦
The issuer is solely responsible for the content of this announcement.
About AIA Hong Kong & Macau
AIA Group Limited established its operations in Hong Kong in 1931. To date, AIA Hong Kong and AIA Macau have over 18,000 financial planners1, as well as an extensive network of independent financial advisors, brokerage and bancassurance partners. We serve over 3.6 million customers2, offering them a wide selection of professional services and products ranging from individual life, group life, accident, medical and health, pension, personal lines insurance to investment-linked assurance schemes with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high-net-worth customers.
1 as of 31 March 2025
2 Including AIA Hong Kong and AIA Macau's individual life, group insurance and pension customers (as of 31 March 2025)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
Cancer is not typically associated with health benefits, but a new study suggests that it could reduce the risk of dementia for some patients. A study led by the Seoul National University College of Medicine suggests that breast cancer survivors could have a slightly lower chance of developing Alzheimer's disease compared to those who had not undergone treatment. In the study, which was published in JAMA Network Open, data from more than 70,000 breast cancer survivors were compared to a cancer-free control group for an average of 7.3 years. Fda Approves First Ai Tool To Predict Breast Cancer Risk Overall, the breast cancer survivors — particularly those who were 65 and older — showed an 8% lower risk of dementia within the five years following treatment. Those who received radiation showed the most risk reduction, the researchers found. Read On The Fox News App The study was adjusted for other factors that could have contributed to Alzheimer's risk, including age, income levels, geographic location, body mass index, comorbidities (diabetes, hypertension, high cholesterol and chronic kidney disease) and health-related behaviors (smoking, alcohol consumption and physical activity), the study stated. This outcome conflicts with previous concerns about breast cancer patients experiencing cognitive decline after treatment. Bill Gates Reveals 'Next Phase Of Alzheimer's Fight' As He Shares Dad's Personal Battle Chemotherapy has previously been linked to a condition called "chemo brain," where patients experience cognitive decline. "Chemo brain refers to cognitive dysfunction, including thinking and memory problems, that occur in patients with cancer during and after chemotherapy," the researchers wrote. Rates Of Dementia Are Lower In People Who Eat This Specific Diet, Research Shows This is different from Alzheimer's, however — with "chemo brain," the cognitive impairment is described as "subtle" and doesn't keep the patient from retrieving remote memories. "Concerns about chemo brain and the long-term adverse effects of breast cancer treatment on cognition are common, but our findings suggest that this treatment does not directly lead to AD," the researchers noted. In fact, they stated, some studies have shown that certain drugs given to breast cancer patients can help to reduce the formation of amyloid-beta and tau proteins in the brain, which is one of the hallmarks of Alzheimer's. Based on the findings, the researchers recommend that breast cancer patients take steps to reduce modifiable risk factors for Alzheimer's, such as smoking and diabetes, along with receiving standard cancer treatment. The study did have some limitations, the team acknowledged. Information about patients' breast cancer stage and radiation dose was not available. It is also possible that the number of Alzheimer's diagnoses was underestimated. Also, because the study focused on patients with "operable" breast cancer, it may not represent the risk of Alzheimer's among elderly patients, those with "critical comorbidities" or patients with advanced-stage disease, the researchers noted. "We could not evaluate the long-term increase in AD risk because our follow-up period was relatively short (maximum, 11 years)," they wrote. "Additional studies with long-term observation periods are warranted to examine long-term associations between AD risk and breast cancer survival duration." Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer and medical affairs lead in Chicago, pointed out that this topic of research has been explored in previous studies. "There have been many published reports from observational studies of cancer survivors with decreased risk of Alzheimer's disease, but also some that found increased risk," Carrillo, who was not involved in this most recent study, told Fox News Digital. Click Here To Sign Up For Our Health Newsletter The expert cautions against drawing "abrupt conclusions" based on this study. "Previous research on cancer survival and treatment and Alzheimer's risk, much of it cited by the authors of this article, has produced mixed — even contradictory — results," Carrollio said. "More research is needed — especially longer studies in more representative study populations." The most interesting aspect of this study, Carrillo said, is the finding that radiation therapy was associated with 23% Alzheimer's risk reduction, while other cancer treatments showed no risk reduction. This could be due to radiation's capability to lower inflammation levels, the expert suggested. For more Health articles, visit "Lowering inflammation in the body and brain can reduce amyloid beta or slow amyloid beta production, delaying the onset of symptomatic Alzheimer's," she said. "More research is needed to see if this is, in fact, the case." Approximately 7.2 million Americans aged 65 and older are currently living with Alzheimer's, according to the Alzheimer's Association. Fox News Digital reached out to the study researchers for article source: Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
Yahoo
a day ago
- Yahoo
Lunit partners with Microsoft to develop AI cancer diagnostic tools
South Korean AI company Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice. According to Lunit, the partnership aligns with its vision to create AI tools that fit smoothly into everyday clinical care. The collaboration will involve Lunit and Microsoft's development of a tool for customising AI models that will be embedded into Microsoft's Azure cloud platform, thereby allowing Lunit users to customise their AI models using site-specific clinical data. Lunit adds that the approach will mitigate cross-site model performance variability, which it views as a key hurdle in the deployment of AI diagnostics in real-world clinical settings. The developer also plans to use Microsoft's agentic AI frameworks, which are designed to support intelligent task automation, to develop workflow automation tools. According to Lunit, these solutions will simplify clinical decision-making and improve operational efficiency for its AI cancer diagnostic tools. Lunit's AI tools include the SCOPE HER2 algorithm for human epidermal growth factor receptor 2 (HER2) biomarker evaluation in metastatic colorectal cancer (mCRC) patients undergoing HER2-targeted therapy, and INSIGHT DBT for identifying breast cancer in mammogram images. Lunit CEO Brandon Suh commented: 'Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the US and beyond.' According to GlobalData analysis, the use of AI across healthcare is rapidly advancing, with the market projected to reach a valuation of around $19bn by 2027. Radiology has emerged as one of the most common areas in which AI is being applied – chiefly as a means to drive efficiencies and glean insights that humans evaluating radiologic images could miss. Naveen Valluri, general manager of health and life sciences data and AI at Microsoft, commented: 'With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations. 'By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we're accelerating the development of integrated solutions for radiology and beyond.' "Lunit partners with Microsoft to develop AI cancer diagnostic tools" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Bloomberg
a day ago
- Bloomberg
Singapore Is Training Asia's Next Generation of Pandemic Trackers
By and Alfred Cang Save Each week we bring you insights into one of Asia's most dynamic economies. If you haven't yet, please sign up here. This week, reporter Karoline Kan looks into a training program that's helping health specialists get ahead of the next pandemic, Alfred Cang uncovers the local roots of an iconic (and troubled) food company, and Katie Turner reviews deviled cashews at a Sri Lankan restaurant on Boon Tat Street.
